TREATMENT BIOPHARMACEUTICAL MATERIALS

Brand Owner (click to sort) Address Description
CELLTRION Celltrion Holdings, Co.,Ltd. 5F, 19, Academy-ro 51beon-gil, Republic of Korea Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals;[ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; ] agents for immunity adjustment, namely, pharmaceutical preparations for the [ prevention and ] treatment of disorders of the immune system; biological preparations for medical purposes; [ amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; ] biopharmaceuticals for the treatment [ and prevention ] of [ infectious diseases, tumor-related diseases, ] auto-immune diseases, [ hormone-deficiency diseases; ] biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, [ hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; ] biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals [ ; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ];Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products;[ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service];Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [ ; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ];
CELLTRION Celltrion Holdings, Co.,Ltd. 5F, 19, Academy-ro 51beon-gil, Republic of Korea Treatment of biopharmaceutical materials, namely, processing finished products from raw biopharmaceutical materials; treatment service of biopharmaceutical materials for others, namely, processing finished products from raw biopharmaceutical materials for others; contract manufacturing service for others in the field of biopharmaceuticals; contract manufacturing service in the field of pharmaceuticals;The mark consists in a figure of three green circles and the word CELLTRION in black, in which said three green circles have a thin-lined circle, a thick-lined circle and a solid circle.;Page 2, line 28 through 30, medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others should be deleted in class 42.;[ Vaccines; medicines for sensory organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of sensory organ; agents affecting peripheral nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the peripheral nervous system; agents for immunity adjustment, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system; biological preparations for medical purposes; amino acids for medical purposes; antibiotic preparations; agents for respiratory organs, namely, pharmaceutical preparations for the prevention and treatment of disorders of respiratory organs; chemotherapeutics; reagents for measuring Hepatitis B Surface antibody, namely, medical diagnostic reagents for detecting Hepatitis B surface antibody; diagnostic preparations for medical use; AIDS, acquired immune deficiency syndrome diagnostic agents, namely, diagnostic preparation for medical use; AIDS, acquired immune deficiency syndrome vaccines; agents affecting central nervous system, namely, pharmaceutical preparations for the treatment and prevention of disorders of the nervous system; veterinary vaccines; agents for tumor treatment, namely, pharmaceutical preparations for the treatment of tumor; agents for urogenital organs, namely, pharmaceutical preparations for the treatment and prevention of disorders of urogenital organs; kits for protein test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a protein related to a disease; kits for gene test, namely, diagnostic kits, namely, primary reagents for detecting the presence of a gene related to a disease; biopharmaceuticals for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone-deficiency diseases; biopharmaceutical preparations, namely, polypeptides, proteins, monoclonal antibodies, hormones for the treatment and prevention of infectious diseases, tumor-related diseases, auto-immune diseases, hormone deficiency diseases; biotherapeutic preparations and substances for medical purposes; biotechnological preparations for medical purposes; pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, chemical reagents for medical purposes; chemico-pharmaceutical preparations ];The color(s) black, green is/are claimed as a feature of the mark.;Wholesale distributorships featuring pharmaceutical products; retail store services featuring pharmaceutical products; business intermediary services in the field of pharmaceutical products; wholesale distributorships featuring biopharmaceutical products; retail store services featuring biopharmaceutical products; business intermediary services in the field of biopharmaceutical products;[ Rental of medical and health care equipment; medical product information, namely, providing an interactive holistic web site featuring health information and patient initiated, patient authorized, fee-for-service, holistic approach distance healing sessions based on the patient's specific set of symptoms, medical profile and medical record analysis and patient benefit information concerning organic and holistic products and services; medical clinics, namely, conducting clinical trials of new products for medical purposes; hospitals; medical assistance services; biopharmaceutical consulting service ];Pharmaceutical research and development; [ bacteriological research; biological research; research and development for new products for others; material testing; chemistry services, namely, chemistry consultation; chemical research and analysis; technology outsourcing services on biopharmaceuticals manufacturing, namely, conducting biopharmaceutical research services for others; consulting services in the field of biotechnology; pharmaceutical drug development services with animal cell; scientific research related to genetically modified plant; biotechnology research; ] biopharmaceutical research and development [; medical product testing; technology outsourcing services on selecting medicines, namely, conducting pharmaceutical research services for others ];
FNT CJ CHEILJEDANG CORPORATION CJ Cheiljedang Center, 330, Dongho-ro, Jung-gu, Seoul 04560 Republic of Korea Treatment of biopharmaceutical materials; Custom manufacture of polyclonal antibody pharmaceuticals; Custom manufacturing services in the nature of processing of phytohormones; Custom manufacturing services in the nature of processing of chemical reagents; Processing of food and beverage; Fermenting of food being food processing; Food processing, namely, processing of health supplements food as the main component of the grain; Processing of vitamin enriched nutraceutical preparations for use in food manufacture; Processing of raw materials for the manufacture of food and beverages; Food preservation services;
PHYTO POWER LIFE IS LONG srg invest ag c/o Inspecta Revision AG, Simonstrasse 7 CH-9016 St. Gallen Switzerland Treatment of biopharmaceutical materials; processing of bio-pharmaceutical materials for others;Pharmaceutical products; dietary supplements for humans and animals; herbal supplements; food supplements for medical use consisting of amino acids, minerals and/or trace elements; dietetic substances consisting of vitamins, minerals and trace elements and of secondary plant substances, either individually or in combination; vitamin preparations, in particular as nutritional supplements and/or for medical purposes; phytotherapy preparations for medical use; plant extracts for pharmaceutical use;Technical consultant services with respect to research services in the field of foods and food supplements; research and development of products; research and development in the field of biotechnology; research and development for the pharmaceutical industry; providing information with respect to medical and scientific research in the field of pharmaceutical products; scientific and medical research and development;
PINPOINT Horizon Discovery Limited 8100 Cambridge Research Park, Waterbeach Cambridge CB259TL United Kingdom Treatment of biopharmaceutical materials; custom manufacture of cells and vectors for diagnostic, medical and commercial applications in relation to cell and gene therapies; consultancy and advisory services relating to the aforesaid services;collections of DNA and gene sequences for research and reference purposes provided as DNA microarrays and DNA chips;Diagnostic preparations and materials generated by the use of base editing components for medical purposes; chemical preparation for use in DNA analysis for medical purposes; biological preparations in the nature of DNA, RNA and parts thereof for medical purposes; biological preparations in the nature of DNA extracts for medical purposes; biological preparations in the nature of gene editing enzymes for medical purposes; biological preparations in the nature of protein cell lysates, genomic DNA preparations and Formalin Fixed, Paraffin Embedded (FFPE) engineered tumour tissue mimics for medical diagnostic use; biological preparations in the nature of biological, biochemical and chemical reagents, including living cells, genetically modified cells and vectors, genomic DNA, cell cultures and mutant and normal isogenic cell line pairs, peptides, proteins and nucleic acids or complexes of these molecules for medical use; all the aforesaid goods being medical preparations;Biological preparations in the nature of eukaryotic cells, isogenic cell lines and bio-production cell lines generated using base editing engineering for scientific, laboratory or medical research; reagents, plasmids and assays for scientific, genetic and medical research; genomic reference control samples for medical laboratory use; molecular biology research tools, in the nature of chemical, biological and biochemical reagents; biological preparations in the nature of separate base editing components including mRNA, rRNA, gRNA, deaminase, nickase, ribonucleotide protein (RNP) for use in scientific, laboratory or medical research; biological preparations in the nature of genetically modified cells and vectors for scientific and research purposes; biological and chemical reagents including complexes of these molecules for research and for clinical and industrial use;Custom cell-line engineering services; gene base-editing services for research purposes; gene engineering services; research and development services in the creation of databases or collections of information on biologicals including cells and cell lines for research purposes; creating and providing databases or collections of information on normal and mutated genes for research purposes; providing DNA reference standards for research purposes; providing DNA reference databases being collections of DNA and gene sequences for research purposes; research on cell line models; contract research on cell line models; research and development services relating to targeting therapies to individuals; establishing patient genotypes for research or analysis purposes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling for research purposes; design of clinical trials for research purposes; research and development in re-positioning existing drugs from other therapeutic indications; consultancy and advisory services relating to the aforesaid services; all of the aforesaid services relating to biological and medical research and research and development in the field of cells and cell therapies, genome editing, genetic engineering and gene therapies;
T-CHARGE NOVARTIS AG CH-4002 Basel 4002 Switzerland Treatment of biopharmaceutical materials; custom manufacturing to the order and requirements of a customer of cells and vectors for diagnostic and medical applications in relation to cell and gene therapies;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The recycling of metal materials is performed by efficiently recovering the metal materials from component materials of a process cartridge. To achieve this object, there is provided a method of recycling a process cartridge containing a toner, wherein in a crushing process of a process cartridge containing a recovered toner, a container shape of the process cartridge is subjected to disassembly treatment to an extent of main component parts, the toner is recovered by suction in a step of disassembly treatment, metal materials, such as ferrous materials and aluminum materials, in component materials of the process cartridge are subjected to separation treatment after the step of disassembly treatment, and each of the materials is subjected to melting treatment thereby to change the materials into forms capable of reuse as ferrous materials and aluminum materials.